Pain News and Research

Latest Pain News and Research

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

New statewide program in North Dakota aims to stem opioid misuse

New statewide program in North Dakota aims to stem opioid misuse

ACA's Medicaid expansion associated with increase in prescriptions for opioid use disorder treatment

ACA's Medicaid expansion associated with increase in prescriptions for opioid use disorder treatment

FDA approves marketing of brainsway deep transcranial magnetic stimulation system for OCD

FDA approves marketing of brainsway deep transcranial magnetic stimulation system for OCD

Hologic’s Cynosure division partners with Porter Instrument to distribute nitrous oxide and oxygen system

Hologic’s Cynosure division partners with Porter Instrument to distribute nitrous oxide and oxygen system

CartiHeal and LSU Health successfully enroll first two patients in Agili-C IDE pivotal study

CartiHeal and LSU Health successfully enroll first two patients in Agili-C IDE pivotal study

OUHSC gets $20 million grant to advance research and patient care for Oklahomans

OUHSC gets $20 million grant to advance research and patient care for Oklahomans

Federal advisory group publishes recommendations on prevention of acute, chronic pain

Federal advisory group publishes recommendations on prevention of acute, chronic pain

Seeking solutions to treat scleroderma

Seeking solutions to treat scleroderma

Podcast: KHN’s ‘What the Health?’ See you in court!

Podcast: KHN’s ‘What the Health?’ See you in court!

FDA grants approval for first generic version of epinephrine auto-injector

FDA grants approval for first generic version of epinephrine auto-injector

Exercise reduces symptoms and fatigue in patients with chronic kidney disease

Exercise reduces symptoms and fatigue in patients with chronic kidney disease

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

Sun Pharma receives U.S. FDA approval for CEQUA to treat patients with dry eye disease

Sun Pharma receives U.S. FDA approval for CEQUA to treat patients with dry eye disease

Seattle Children's opens new clinic to provide convenient access to pediatric specialty care services

Seattle Children's opens new clinic to provide convenient access to pediatric specialty care services

Curious case of the lost contact lens - after 28 years!

Curious case of the lost contact lens - after 28 years!

Preventing ACL injuries in high school athletes

Preventing ACL injuries in high school athletes

Study reveals how immune cells in the brain influence sexual behavior

Study reveals how immune cells in the brain influence sexual behavior

Johns Hopkins expert panel develops first set of operation-specific opioid prescribing guidelines

Johns Hopkins expert panel develops first set of operation-specific opioid prescribing guidelines

‘No one is ever really ready’: Aid-in-dying patient chooses his last day

‘No one is ever really ready’: Aid-in-dying patient chooses his last day

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.